Jun 17, 2014 7:00am EDT Can-Fite Completes Patient Enrollment in its Phase II/III Psoriasis Trial; Final Results are expected in Q1 2015
Jun 10, 2014 7:00am EDT Can-Fite to Participate in Newport Coast Securities Conference in New York & ROTH Conference in London
Jun 09, 2014 7:00am EDT Can-Fite Subsidiary OphthaliX Provides an Update on its Clinical Developments and Strategic Plans
Jun 02, 2014 7:00am EDT Can-Fite Announces that the US FDA has Agreed with its Phase II Liver Cancer Protocol
May 07, 2014 11:41am EDT Can-Fite Receives Patent in European Union for Treatment of Liver Function Following Surgery
Apr 21, 2014 7:00am EDT Can-Fite Initiates the Development of an A3AR Biomarker Test Kit to Predict Patients' Response to Company's Drugs
